Digital Phenotype for COVID-19 Outcomes in Immunosuppressed Adults
Author Information
Author(s): Leston Meredith, Kar Debasish, Forbes Anna, Jamie Gavin, Wimalaratna Rashmi, Jiwani Gunjan, Ordóñez-Mena José M., Stewart Daniel E., Whitaker Heather, Joy Mark, Lee Lennard Y. W., Hobbs F. D. Richard, de Lusignan Simon
Primary Institution: Nuffield Department of Primary Care Health Sciences, University of Oxford
Hypothesis
Can a digital phenotype effectively subdivide adult immunosuppressed COVID-19 outcomes?
Conclusion
The study developed a digital phenotype that differentiates COVID-19 mortality risks among immunosuppressed patients.
Supporting Evidence
- Immunosuppressed patients have worse COVID-19 outcomes compared to immunocompetent individuals.
- The digital phenotype allows for nuanced extraction of patient data.
- COVID-19 mortality risks vary significantly among different immunosuppressed categories.
Takeaway
This study created a new way to categorize immunosuppressed patients to better understand how COVID-19 affects them.
Methodology
A rapid scoping review was conducted to assess COVID-19 mortality across immunosuppressed categories, leading to the creation of a digital phenotype for data extraction.
Potential Biases
The reliance on existing literature and the subjective nature of the scoping review may introduce bias.
Limitations
The study's rapid nature and lack of a pre-published protocol limit its generalizability and transparency.
Participant Demographics
The study focuses on adult immunosuppressed patients, but specific demographic details are not provided.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website